Safety concerns
A Phase 2 Trial of 4 Weeks of ACH-126,443 in Comparison With Continued Lamivudine in Stable Triple Antiretroviral Combination Therapy in HIV-Infected Subjects With Modestly Detectable Viral Load
Sponsor study identifier
interventional
60
1 country
13
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
May 2003
Actual (reported)To determine safety and efficacy of ACH-126,443 on the treatment of adults with HIV infection who have modestly detectable viral load while on stable triple combination antiretroviral therapy including 3TC.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2003
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 21, 2002
Actual (reported)June 25, 2002
Actual (reported)May 2003
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Body Positive, Inc.
Phoenix, Arizona, 85006, United States
Los Angeles, California, United States
Pacific Horizon Medical Group, Inc.
San Francisco, California, 94115, United States
Community Health Care Center One, Inc.
Fort Lauderdale, Florida, 33306, United States
South Shore Hospital
Miami Beach, Florida, 33160, United States
AIDS Research Consortium
Atlanta, Georgia, 30308, United States
Chicago, Illinois, United States
First Submitted
June 21, 2002
First Posted
June 25, 2002
Study Completion
May 2003
Actual (reported)Last Updated
December 30, 2015
Record last verified: 2015-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
Contact the study team to confirm eligibility.
St. Lukes Roosevelt Hospital
New York, New York, 10019, United States
Stony Brook University Infectious Disease, Dept. of Medicine
Stony Brook, New York, 11794-8153, United States
Houston, Texas, 77098, United States
Houston, Texas, United States
Hampton Road Medical Specialists
Hampton, Virginia, 23666, United States
Swedish Medical Center
Seattle, Washington, 98122, United States